Navigation Links
Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year

- Both capital sales and rental revenue increase 12.0 percent demonstrating

balanced growth - Hill-Rom reporting for first time since separation; strategic investments

showing results - Management updates financial guidance based on year to date performance

and operational momentum

BATESVILLE, Ind., May 13 /PRNewswire-FirstCall/ -- Hill-Rom Holdings, Inc. (NYSE: HRC), reporting for the first time since the spin-off of the funeral services business, today announced unaudited financial results for its fiscal second quarter ended March 31, 2008. Results included revenue of $375.2 million, a $40.2 million or 12.0 percent increase from $335.0 million in the prior year comparable period. On a constant currency basis, revenue increased 9.0 percent.

Consolidated net income from continuing operations, which excludes results attributable to the funeral services business and certain other costs associated with the separation, was $9.4 million, or $0.15 per fully diluted share -- a decrease of 40.0 percent. On an as adjusted basis, fully diluted earnings per share from continuing operations for the second quarter of fiscal 2008 were $0.26 compared to the same amount per fully diluted share in 2007. Adjustments to the current year relate to a number of costs associated with the separation of the funeral services business, including non-recurring costs of separation, a stock modification charge to maintain the value of existing equity compensation, and a loss on the extinguishment of debt. The adjustment in the prior year related to antitrust litigation expenses.

On March 31, 2008, we completed the spin-off of our funeral services business operage of sales 39.2% 37.0% 32.2% 39.8% 36.4%

Litigation and special

credits/(charges), net - (2.3) 1.6 - (0.2)

Operating profit 20.4 23.4 41.2 14.7 30.0

Other income/(expense) (3.5) (2.8) (1.2) (4.1) (4.4)

Income tax expense 7.5 8.2 11.1 3.8 9.9

Income from continuing operations $9.4 $12.4 $28.9 $6.8 $15.7

Diluted earnings per share:

Earnings per share from

continuing operations $0.15 $0.20 $0.46 $0.11 $0.25

Average common shares outstanding

- diluted (thousands) 62,566 62,403 62,393 62,241 61,944

Dividends per common share $0.285 $0.285 $0.285 $0.285 $0.285

Consolidated Cash Flows from

Operations *

Cash flow from operations $84.1 $120.1 $88.5 $60.6 $34.8

Less: capital expenditures (30.7) (26.0) (34.6) (28.4) (44.9)

Consolidated free cash flow $53.4 $94.1 $53.9 $32.2 $(10.1)

Cash, cash equivalents and

investment securities $194.5 $289.8 $194.3 $146.1 $117.7

Hill-Rom Capital Expenditures $28.7 $23.7 $27.2 $23.4 $42.0

Hill-Rom Depreciation &

Amortization $25.5 $24.4 $21.5 $22.8 $22.6

* Consolidated cash flow amounts are "as reported" and thus include cash

flows from funeral services business through March 31, 2008.

Consolidated Results - Highlights

Revenues from Continuing Operations

Y/Y Adj/

($ In Millions) Q2 2008 Foreign Q2 2008 Q2 2007 Actual

Actual Exchange Adjusted Actual % Change

Acute Care $230.9 $(2.5) $228.4 $219.4 4.1%

Post Acute Care 48.0 - 48.0 42.9 11.9%

International and Surgical 97.0 (7.6) 89.4 73.2 22.1%

Total Eliminations (0.7) - (0.7) (0.5) 40.0%

Total $375.2 $(10.1) $365.1 $335.0 9.0%

($ In Millions) YTD Y/Y YTD YTD Adj/

2008 Foreign 2008 2007 Actual

Actual Exchange Adjusted Actual % Change

Acute Care $442.2 $(3.7) $438.5 $424.3 3.3%

Post Acute Care 96.1 - 96.1 88.4 8.7%

International and Surgical 180.5 (14.0) 166.5 144.7 15.1%

Total Eliminations (2.2) - (2.2) (1.4) 57.1%

Total $716.6 $(17.7) $698.9 $656.0 6.5%

Non-GAAP Financial Disclosures and Reconciliations - Second Quarter

While Hill-Rom reports financial results in accordance with U.S. GAAP,

this press release includes non-GAAP measures. These non-GAAP measures are

not in accordance with, nor are they a substitute for, GAAP measures.

Hill-Rom uses the non-GAAP measures to evaluate and manage its operations

and provides the information to assist investors in performing financial

analysis that is consistent with financial models developed by research

analysts. Investors should consider non-GAAP measures in addition to, not

as a substitute for, or as superior to, measures of financial performance

prepared in accordance with GAAP.

Income from Income from

Continuing Operations Continuing Operations

Second Quarter - 2008 - 2007

Pre- Income Diluted Pre- Income Diluted

tax Taxes EPS tax Taxes EPS

Income from continuing

operations - GAAP $16.9 $7.5 $0.15 $25.6 $9.9 $0.25


Antitrust litigation - - - 1.2 0.8 0.01

Special charges - - - 0.2 (0.1) -

Stock modification charge 5.8 2.1 0.06 - - -

Loss on extinguishment of

debt 3.2 1.2 0.03 - - -

Separation costs 1.5 0.4 0.02 - - -

Income from continuing

operations - Adjusted $27.4 $11.2 $0.26 $27.0 $10.6 $0.26

Income from Income from

Continuing Operations Continuing Operations

Year-to-Date - 2008 - 2007

Pre- Income Diluted Pre- Income Diluted

tax Taxes EPS tax Taxes EPS

Income from continuing

operations - GAAP $37.5 $15.7 $0.35 $55.6 $20.9 $0.56


Antitrust litigation 2.3 0.9 0.02 1.2 0.8 0.01

Special charges - - - 0.2 (0.1) -

Stock modification charge 5.8 2.1 0.06 - - -

Loss on extinguishment of

debt 3.2 1.2 0.03 - - -

Separation costs 1.6 0.4 0.02 - - -

Income from continuing

operations - Adjusted $50.4 $20.3 $0.48 $57.0 $21.6 $0.57

Selected Summary Balance Sheet Schedule

Pro Forma

03/31/2008 12/31/2007 9/30/2007

(1) (2)


Current Assets

Cash and cash equivalents $145.9 $72.9 $81.5

Trade accounts receivable, net of

allowances 362.1 340.9 491.6

Inventories 113.3 102.5 154.9

Other current assets 112.3 93.6 166.4

Total current assets 733.6 609.9 894.4

Equipment leased to others, net 192.8 189.5 185.7

Property, net 126.0 126.4 224.0

Other assets 584.5 580.1 812.9

Total Assets $1,636.9 $1,505.9 $2,117.0


Current Liabilities

Trade accounts payable $122.8 $72.3 $104.0

Other current liabilities 203.2 186.9 235.6

Total current liabilities 326.0 259.2 339.6

Long-term debt 126.6 100.6 348.6

Other long-term liabilities 131.4 122.2 151.0

Total Liabilities 584.0 482.0 839.2

Shareholders' Equity 1,052.9 1,023.9 1,277.8

Total Liabilities and Shareholders'

Equity $1,636.9 $1,505.9 $2,117.0

(1) Reflects the separation of our funeral services business as included

in Current Report on Form 8-K filed with the

Securities and Exchange Commission on March 14, 2008.

(2) Reflects consolidated balance sheet of medical technology and funeral

services business prior to completion

of separation of funeral services business.

Financial Guidance for Fiscal Year 2008

2008 Range

($ in millions, except EPS) 2007 Low High

Net Revenues

Health Care sales $941 $1,009 $1,022

Health Care rentals 416 455 464

Total revenues 1,357 1,464 1,486

vs prior year actual +5.3% +7.9% +9.5%

Health Care sales gross margin % 41.9% 41.9% 43.2%

Health Care rentals gross margin % 50.2% 50.8% 52.5%

Operating Expenses* 482 530 547

Operating Income* 121 125 139

Tax Rate 33.7% 37.0% 37.0%

Income from Continuing Ops* $70 $74 $83

Earnings per share - GAAP $1.13 $1.05 $1.18

Earnings per share - Adjusted* $1.13 $1.18 $1.32

* Excludes special charges recognized in Q1 2008, as well as one

time charges incurred in Q2 2008 for equity award modification,

debt extinguishment, and other costs related to the spin-off of

the funeral services business. See Non-GAAP Financial Disclosures

and Reconciliations on the previous page.

ting under the Batesville Casket name. Accordingly, the results of operations of the funeral services business, including certain separation costs and other income and expenses assigned to the funeral services business, have been presented as discontinued operations for all periods presented in the Condensed Consolidated Statements of Income.

Management Comments

Peter H. Soderberg, president and CEO of Hill-Rom, commented, "We are pleased that the strategic investments we have pursued over the last five quarters are helping to produce the balanced, double-digit growth experienced in both our capital sales and rental revenue. While we continue to face challenges due to competitive pressures and commodity cost increases, this quarter maintains our trend of accelerating revenue growth. Now that the separation of the health care and funeral services businesses is behind us, we can singularly focus on the continued execution of our strategic imperatives to develop our business more rapidly across the continuum of care, and around the world, while expanding our margins."

Soderberg continued, "All of our reporting segments showed both capital sales and rental revenue growth. Our North America Acute Care segment revenue performance was led by 15.5 percent growth in rental revenue derived from our proprietary therapy rental products. Our International and Surgical segment revenue once again showed significant growth of over 22 percent growth on a constant currency basis, reflecting the success of several new products and the beginnings of our initiative to build our franchise in medicalized long term care in Europe. Finally, our North America Post-Acute Care segment continues to provide important growth opportunities as evidenced by the 11.9 percent revenue increase on the strength of a significant increase in capital product sales."

"Today we are updating our guidance to reflect our second quarter results and the confidence that our strategic initiatives are on track. During the second half we expect our revenue growth rate to be mid-to-high single digits, gross profit to increase ten to twenty percent, and operating income as adjusted to increase well in excess of gross profit as we experience better operating expense leverage. These projections assume that we continue to see the robust pipeline of capital spending projects in North America that we see at this time," Soderberg concluded.

Other second quarter revenue highlights regarding Hill-Rom business segments:

-- North America Acute Care. Hill-Rom North America Acute Care revenue

increased $11.5 million, or 5.2 percent, to $230.9 million--including

$2.5 million of favorable exchange rate movements. Capital sales

increased 1.6 percent, or $2.5 million, due in part to the initial

shipments of our new TotalCare Connect(TM) and TotalCare Connect

Bariatric(TM) bed platforms in March. These platforms provide

differentiated connectivity and a user-friendly caregiver interface.

This growth, and strong sales increases in our maternity beds and

stretchers, was, for the most part, offset by competitive pressure on

our mid-acuity patient support systems and architectural products.

North America rental revenue increased by $9.0 million, or 15.5

percent, during the quarter. Therapy rental products in acute care

grew in excess of 25 percent, due to a strong influenza and pneumonia

season, sharply higher volumes from 2007 product launches in bariatric

and wound care products, and the impact of a recent sole-source GPO

contract win. Moveable medical equipment rentals continued to reflect

year-over-year declines, although at much more modest rates.

-- International and Surgical. Hill-Rom International and Surgical

capital and rental revenue increased $23.8 million, or 32.5 percent, to

$97.0 million. Constant currency growth of 22.1 percent was

principally driven by strong performance in Europe, Asia, and within

our surgical business. Capital sales, up $22.2 million, were

positively affected by increased sales in Europe as a result of the

AvantGuard(TM) 800 and 1200 beds and increased furniture sales in both

acute care and long-term care markets. Rental revenue was also higher

by $1.6 million due to favorable exchange rates and, we believe,

increases in our market share.

-- North America Post-Acute Care. Hill-Rom North America Post-Acute Care

revenue increased $5.1 million, or 11.9 percent, to $48.0 million.

Significant investments in new product development, sales channel

additions, and information technology system enhancements during 2007

are beginning to yield results across most of our post acute care

product lines. Capital sales revenue increased by $2.7 million, or

46.6 percent, primarily due to increased sales channel focus and

improved support surface, frame and furniture sales. Sales of The

Vest(R) respiratory care product continued to show solid increases,

rising $1.0 million over the prior year quarter. Rental revenue

increased $2.4 million, or 6.5 percent, primarily related to increased

activity associated with our therapy rentals to the home and higher

revenue on The Vest(R). The overall favorability experienced in these

areas was partially offset by continued softness in our low-end

surfaces within our extended care rental lines.

Other Second Quarter Financial and Operational Highlights

Gross Profit and Operating Expenses:

-- Hill-Rom gross profit grew $15.1 million, or 9.9 percent, although

gross margin declined 80 basis points to 44.6 percent, primarily due to

strong international sales, which generally carry a lower margin. Two

million dollars of start-up costs associated with the new Monterrey,

Mexico facility and higher fuel and other commodity costs negatively

impacted gross profit and margins.

-- Other operating expenses increased $24.9 million, or 20.4 percent. The

higher expense levels were primarily due to increased spending

previously outlined as part of our strategic plan, including research

and development (up 18.5 percent over the prior year quarter to $14.8

million), higher sales and marketing expenses of 14.8 percent, and

currency impacts. Other unfavorable expense items during the quarter

include non-recurring separation-related charges of $7.3 million, and a

$4.1 million unfavorable swing for self insurance reserves.


-- Expenses associated with the separation of the health care and funeral

services businesses into independent companies resulted in the

inclusion of the following items in Hill-Rom's income from continuing

operations on a GAAP basis (these items represent pre-tax adjustments

made in determining Hill-Rom's as adjusted fully diluted earnings per

share figure for continuing operations):

-- Stock modification charge of $5.8 million

-- Debt extinguishment costs of $3.2 million

-- Other separation costs of $1.5 million

-- Cash flow from operations, which includes cash flows from the funeral

services business through March 31, 2008, was $84.1 million for the

second quarter, up $49.3 million, or 141.7 percent, from the prior year

comparable period. Substantially all of the increase in cash flow for

the quarter was generated by Hill-Rom.

Please see the attached schedules for additional information, including reconciliations of earnings in accordance with U.S. generally accepted accounting principles ("GAAP") to as adjusted income and earnings per share, condensed financial information, summary balance sheet information, and segment sales summaries.

For a more complete review of Hill-Rom's second quarter results, please refer to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, which will be filed later this week.

Financial Guidance Summary For 2008

Upon completion of the second quarter, management has determined that full year guidance will be adjusted as follows: Hill-Rom consolidated revenue guidance range for fiscal 2008 will increase to $1.464 - $1.486 billion from $1.427 - $1.476 billion; GAAP earnings per fully diluted share from continuing operations will decrease to $1.05 - $1.18 from $1.11 - $1.30, reflecting newly included non-recurring separation costs. Adjusted earnings per fully diluted share from continuing operations will increase to $1.18 - $1.32 from $1.13 - $1.32. Financial guidance in tabular format is included as an attachment.

Hill-Rom Holdings, Inc. provides earnings per share guidance on an adjusted basis from continuing operations because the company's management believes that the presentation provides useful information to investors. This measure may exclude such items as strategic developments and significant litigation. Special items may be highly variable, difficult to predict, and of a size that sometimes have substantial impact on the company's reported operations for a period. Often, prospective quantification of such items is not feasible. Management uses these measures internally for planning, forecasting and evaluating the performance of the business, including evaluating results relative to employee performance compensation targets. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

Additional assumptions and discussion will be provided during the Company's conference call to be held later tomorrow morning. Information to access the webcast is provided below.

Conference Call Replay and Webcast

The company will sponsor a conference call and webcast for the investing public at 8 a.m. EDT, 7 a.m. CDT, on Wednesday, May 14, 2008. During the event, management will discuss the results for the fiscal second quarter ended March 31, 2008, along with expectations for the remainder of fiscal 2008. The webcast is available at or and will be archived on the company's Web site through May 13, 2009 for those who are unable to listen to the live webcast. A replay of the call is also available through May 21, 2008 at 888-203-1112 (719-457-0820 International). Code 2411564 is needed to access the replay.


Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, and information technology solutions. Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom ... enhancing outcomes for patients and their caregivers.

Disclosure Regarding Forward-Looking Statements

Certain statements in this press release contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections. The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them or by comparable terminology. The absence of such terms, however, does not mean that the statement is not forward-looking. It is important to note that forward- looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward- looking statements. Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large group purchasing organizations, whether the Company's new products are successful in the marketplace, changes in customers' Medicare reimbursements, collections of accounts receivable, compliance with FDA regulations, antitrust litigation, potential exposure to product liability or other claims, failure of the Company's announced strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, disruptions in the Company's business or other adverse consequences resulting from the recent spin-off of the funeral service business, failure to realize the anticipated benefits of the spin-off, failure of the Company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, increased costs or unavailability of raw materials, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters. For a more in depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the period ended September 30, 2007, its Current Report on Form 8-K filed with the SEC on March 17, 2008, and the Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, which will be filed later this week. The Company assumes no obligation to update or revise any forward-looking statements.

Hill-Rom Holdings, Inc.

Condensed Financial Information


(Dollars in millions except per share data)

Quarterly Periods

Condensed Statement of Earnings 2Q08 1Q08 4Q07 3Q07 2Q07

Net revenues

Health Care sales $255.3 $229.5 $276.6 $225.4 $227.9

Health Care rentals 119.9 111.9 95.4 103.1 107.1

Total revenues 375.2 341.4 372.0 328.5 335.0

Cost of revenues

Health Care cost of goods sold 150.3 136.5 162.0 132.3 130.2

Health Care rental expenses 57.6 52.9 50.6 50.7 52.6

Total cost of revenues 207.9 189.4 212.6 183.0 182.8

Gross profit

Health Care sales 105.0 93.0 114.6 93.1 97.7

Health Care rentals 62.3 59.0 44.8 52.4 54.5

Total gross profit 167.3 152.0 159.4 145.5 152.2

As a percentage of sales 44.6% 44.5% 42.8% 44.3% 45.4%

Operating expense 146.9 126.3 119.8 130.8 122.0

As a percenta

SOURCE Hill-Rom Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hill-Rom to Present at the Citi Healthcare Conference
2. Hill-Rom to Present at the Bank of America 2008 Health Care Conference
3. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Second Quarter Earnings Webcast
4. Hill-Roms NaviCare(R) WatchChild(R) Solution Provides Enhanced Information Technology Solutions for Obstetrical Care
5. Hill-Rom Holdings, Inc. Announces Completion of Separation of Hillenbrand Industries Creating Two Public Companies
6. Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket
7. Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology
8. Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery
9. Hill-Rom Introduces Fashionable, Affordable Bed for Home and Post-Acute Care Patients
10. Hill-Rom Announces Singapore Will Be Site for Asia-Pacific Innovation Center
11. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer and distributor ... Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. , ... up-to-date with a version of Asterisk that will receive not only security fixes, ...
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... , ... November 26, 2015 , ... Jobs in hospital ... healthcare professionals and offered by healthcare staffing agency Aureus Medical Group . ... month of October 2015 among those searching for healthcare jobs through the company’s website, ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack ... trailer titles work with any font, giving users limitless opportunities to stylize and ...
(Date:11/25/2015)... OAK BROOK, Ill. (PRWEB) , ... November 25, ... ... sometimes larger and potentially more aggressive than those found on mammography, according to ... cases MRI findings of additional cancers not seen on mammography may necessitate a ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)...  Linden Care, LLC, a retail specialty pharmacy focused ... suffering from chronic pain, said today that it is ... (TRO) enjoining Express Scripts from unilaterally terminating the Pharmacy ... --> --> The company said that ... --> --> In ...
(Date:11/25/2015)... USA , Inc., a leader in ... accuracy of its blood glucose meter systems. Last week ... Cardiovascular Disease in Los Angeles , ... 01 meter and the Assure ® Prism multi-user ... measure glucose levels in blood is essential for people ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan plc (NYSE: ... agreement with the New York State ... of the Sherman Act, and other statutes with the Attorney ... February 2014, to cease marketing and selling the now generic ... settlement, Allergan admits no liability, has released its counterclaims against ...
Breaking Medicine Technology: